DHA/ARA Term Infant Formula Negative Findings Cast Doubt On Launches
This article was originally published in The Tan Sheet
Executive Summary
Negative research results relating to DHA/ARA supplementation of term infant formulas could delay the U.S. launch of formulas containing the fatty acids.
You may also be interested in...
Enfamil LIPIL Future “Unique Blend” Claims Should Be Clarified, NAD Says
Mead Johnson should clarify future marketing claims forEnfamil LIPIL to avoid the implication it is the only infant formula on the market fortified with fatty acids DHA and ARA, the National Advertising Division of the Council of Better Business Bureaus says in a recent decision
Martek DHA/ARA Pregnancy/Nursing Benefits Research Underway
Martek Biosciences is developing DHA and ARA supplements for pregnant/lactating women and for cardiovascular health, CEO Henry Linsert announced during a recent analysts teleconference.
Martek Nutritional Oils Addition To U.S. Infant Formulas Forthcoming
FDA's long-awaited affirmation that Martek Biosciences' nutritional oils are generally recognized as safe came May 17, giving the firm an entry into the approximately $2 bil. U.S. infant formula market.